Ledger.Open graph →
SEC Form D · filed June 18, 2014

PHOENIX BIOTECHNOLOGY INC

Offering
$2.0M
Sold
$852K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN ANTONIO, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Gary T. Salhany · Cuyahoga Falls, OHExec · DirectorGreg F. Gruning · Cuyahoga Falls, OHDirectorStephen S. Sypherd · Philadelphia, PADirectorTadataka M. Yamada · Seattle, WAExec · DirectorW. M. Bryant · Louisville, KYDirectorMark Hauser · New York, NYDirectorDavid W. Davis · Louisville, KYDirectorRichard G. Kent · London, United KingdomDirectorFrank Sena · SEATTLE, WADirectorRobb Monkman · SEATTLE, WADirectorBrian K. Sullivan · Canton, GADirectorChris Allen · Alpharetta, GAExec · DirectorIgniteXL Ventures GP, LLC · Palo Alto, CADirectorMichael Hacke · Pittsburgh, PAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗